Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1

Colorectal cancer (CRC) is one of the major threats to human health worldwide. In the treatment of CRC, chemoresistance affects the efficacy of platinum-based therapies. Oxaliplatin is one of the most commonly used first-line medications for the treatment of CRC; however, chemoresistance is common a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Tingrui, Xiang, Ping, Mao, Haibing, Tang, Shumin, Zhou, Jinyi, Zhang, Yonggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401935/
https://www.ncbi.nlm.nih.gov/pubmed/32765688
http://dx.doi.org/10.3892/etm.2020.8936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401935/
https://www.ncbi.nlm.nih.gov/pubmed/32765688
http://dx.doi.org/10.3892/etm.2020.8936

Ejemplares similares